541 related articles for article (PubMed ID: 16650951)
61. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
Goyanes MJ; Cercenado E; Insa R; Morente A; Alcalá L; Bouza E
Rev Esp Quimioter; 2007 Jun; 20(2):216-21. PubMed ID: 17893759
[TBL] [Abstract][Full Text] [Related]
62. [Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000 - 2001)].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1035-45. PubMed ID: 12899774
[TBL] [Abstract][Full Text] [Related]
63. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli.
Sader HS; Jones RN
Int J Antimicrob Agents; 2005 Feb; 25(2):95-109. PubMed ID: 15664479
[TBL] [Abstract][Full Text] [Related]
64. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.
Fedler KA; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):427-36. PubMed ID: 16938419
[TBL] [Abstract][Full Text] [Related]
65. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008).
Rhomberg PR; Jones RN
Diagn Microbiol Infect Dis; 2009 Dec; 65(4):414-26. PubMed ID: 19833471
[TBL] [Abstract][Full Text] [Related]
66. In vitro evaluation of cefepime and other broad-spectrum beta-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study Group.
Biedenbach DJ; Lewis MT; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):277-83. PubMed ID: 10668586
[TBL] [Abstract][Full Text] [Related]
67. Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006).
Rhomberg PR; Deshpande LM; Kirby JT; Jones RN
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):425-32. PubMed ID: 17662557
[TBL] [Abstract][Full Text] [Related]
68. Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran.
Hadadi A; Rasoulinejad M; Maleki Z; Yonesian M; Shirani A; Kourorian Z
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):301-5. PubMed ID: 18036759
[TBL] [Abstract][Full Text] [Related]
69. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
70. Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
Jones RN; Varnam DJ
Diagn Microbiol Infect Dis; 2002 Dec; 44(4):379-82. PubMed ID: 12543544
[TBL] [Abstract][Full Text] [Related]
71. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).
Paterson DL; Rossi F; Baquero F; Hsueh PR; Woods GL; Satishchandran V; Snyder TA; Harvey CM; Teppler H; Dinubile MJ; Chow JW
J Antimicrob Chemother; 2005 Jun; 55(6):965-73. PubMed ID: 15849262
[TBL] [Abstract][Full Text] [Related]
72. [Monitoring of bacteria resistance in burn patients].
Zhang M; Xu X; Liao P
Zhonghua Wai Ke Za Zhi; 1999 May; 37(5):278-81. PubMed ID: 11829839
[TBL] [Abstract][Full Text] [Related]
73. The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000.
Lauderdale TL; Clifford McDonald L; Shiau YR; Chen PC; Wang HY; Lai JF; Ho M;
Diagn Microbiol Infect Dis; 2004 Mar; 48(3):211-9. PubMed ID: 15023432
[TBL] [Abstract][Full Text] [Related]
74. In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study Group.
Johnson DM; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):291-7. PubMed ID: 10668588
[TBL] [Abstract][Full Text] [Related]
75. Susceptibility of bacterial isolates to cefepime in comparison to other broad spectrum antimicrobial agents at a tertiary care center in Lebanon.
Kanj SS; Chedid M; Araj GF
J Med Liban; 2001; 49(1):13-7. PubMed ID: 11910959
[TBL] [Abstract][Full Text] [Related]
76. Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
Toh HS; Chuang YC; Huang CC; Lee YL; Liu YM; Ho CM; Lu PL; Liu CE; Chen YH; Wang JH; Ko WC; Yu KW; Liu YC; Chen YS; Tang HJ; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S18-23. PubMed ID: 22749054
[TBL] [Abstract][Full Text] [Related]
77. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
Tognim MC; Andrade SS; Silbert S; Gales AC; Jones RN; Sader HS
Int J Infect Dis; 2004 Sep; 8(5):284-91. PubMed ID: 15325597
[TBL] [Abstract][Full Text] [Related]
78. In vitro evaluation of cefepime and other broad-spectrum beta-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samples. The Japan Antimicrobial Resistance Study Group.
Lewis MT; Yamaguchi K; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1999 Dec; 35(4):307-15. PubMed ID: 10668590
[TBL] [Abstract][Full Text] [Related]
79. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007).
Patzer JA; Dzierzanowska D; Turner PJ
J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575
[TBL] [Abstract][Full Text] [Related]
80. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Wang FD; Lin ML; Lee WS; Liu CY
Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
